Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05721131 · ClinicalTrials.gov registry record

NC Thermometer (Gen 3) ISO 80601-2-56 Validation

A clinical trial of Healthy and Fever, sponsored by Natural Cycles.

Completed
Registry status
105
Enrollment target
2
Study locations

NCT05721131: Completed study of Healthy and Fever, sponsored by Natural Cycles.

NCT05721131 is a study of Healthy and Fever that has completed, run by Natural Cycles. The registered enrollment target is 105 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (84% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05721131, a study of Healthy and Fever, has completed, sponsored by Natural Cycles.

COMPLETED
Registry status
105 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this clinical validation is to evaluate the the clinical bias, the limits of agreement, and the clinical repeatability of measuring oral temperature using a new thermometer, NC° Thermometer (Gen 3), compared to a reference clinical thermometer.

Primary Outcome

Clinical bias is the mean difference between the output temperatures of the NC° Thermometer (Gen 3) (DUT) and the reference clinical thermometer (RCT) for a specific reference body site (the mouth) when measured from a selected group of subjects. The clinical bias of the DUT defines closeness between the DUT output temperature and that of the RCT.

Conditions Studied

Healthy Fever Febrile Illness

Interventions

  • DEVICE NC° Thermometer (Gen 3)

Study Locations (2)

California

  • Choice Health Network- Reyes Health Center - Anaheim

New York

  • Natural Cycles - New York

Trial Details

FieldValue
Enrollment Target 105 participants
Start Date 2023-01-10
Est. Completion 2023-04-27
Natural Cycles

2 total trials

What the finished NCT05721131 record still lists

NCT05721131 is an observational study that tracks outcomes without assigning an intervention. The registered 105 participants enrollment target is mid-sized for trials with a published cap, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (84% lower).

The record links to 3 conditions, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which NC° Thermometer (Gen 3) is the first listed.

NCT05721131 reports a single indexed study location in California, New York.

Frequently Asked Questions

What is clinical trial NCT05721131 about?

NCT05721131 is a clinical study titled "NC Thermometer (Gen 3) ISO 80601-2-56 Validation". The purpose of this clinical validation is to evaluate the the clinical bias, the limits of agreement, and the clinical repeatability of measuring oral temperature using a new thermometer, NC° Thermometer (Gen 3), compared to a reference clinical thermometer.

What is the current status of trial NCT05721131?

This trial is currently completed. The enrollment target is 105 participants. The study started on 2023-01-10. Estimated completion is 2023-04-27.

What conditions does trial NCT05721131 study?

This clinical trial studies the following conditions: Healthy, Fever, Febrile Illness.

What interventions are being tested in trial NCT05721131?

The interventions under investigation include: NC° Thermometer (Gen 3) (DEVICE).

Who is sponsoring clinical trial NCT05721131?

This trial is sponsored by Natural Cycles, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05721131 being conducted?

This trial has 2 study locations across California, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05721131's enrollment target sits among peer trials

105 210th of 1090 higher than 879 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03372317 · 105 participants

    Tau PET in Imaging and Cognition: Healthy Adults From 55-90

  • NCT04253964 · 105 participants · Phase 2

    Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy

  • NCT04742452 · 105 participants · NA

    Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears

  • NCT04875429 · 105 participants · NA

    Zenith® Fenestrated+ Clinical Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT05721131, the US trial registry maintained by the National Library of Medicine. NCT05721131 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.